Aclaris Therapeutics's total assets for Q4 2025 were $160.46M, a decrease of -8.59% from the previous quarter. ACRS total liabilities were $57.38M for the fiscal quarter, a 3.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.